https://www.selleckchem.com/pr....oducts/adenosine-cyc
3-1.9). Patients with hematologic malignancies undergoing chemotherapy/radiation and allogeneic hematopoietic stem cell transplant received the most platelet transfusions and more commonly received both platelet types. Of 506 PR PLT units, 5 TRs occurred; 386 CONV PLT resulted in two TRs (p=.7052). Of 51 neonates, 37 received PR PLT without adverse events, including 13 receiving phototherapy. No TTIs were identified in any group. There was no significant difference in rates of transfusion or TRs between PR and CONV PLT.
Like
Comment
Share
